Company intelligence / Profile preview

RealView Imaging

Yokneam Illit, Northern District, Israelrealviewimaging.com ↗

Ownership: Private
Employees: ~19
Development stage: Other

Overview

RealView Imaging has completed the world’s first in-human clinical trials evaluating live 3D holographic imaging in interventional cardiology. Its flagship product, the HOLOSCOPE™‑i system, has received FDA clearance and has been installed at leading hospitals such as Toronto General Hospital. The company continues to develop next-generation products aimed at expanding applications into additional minimally invasive procedures

Therapeutic areas: OncologyCardiovascular
Modalities: Device
Industry: Medical Imaging

Partnerships

Philips Healthcare (clinical study collaboration)Schneider Children’s Medical Center in Israel

Beyond the preview

Go deeper on RealView Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RealView Imaging.

Explore the full profile